Cortendo AB
Records under this name other than patents Cortendo AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 9 of 9 · Back to Cortendo AB
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,166,017 | Method of using ketoconazole and related substances in medicaments for treatment of type II diabetes and methods of treating same Term ended Term ended Dec 14, 2018 · From the USPTO record | Term ended | Term ended Dec 14, 2018 | From the USPTO record |
| US 7,872,008 | Method for treating insulin resistance, abdominal obesity, hypertension, hyperinsulinemia, and elevated blood lipids with a cortisol inhibitor Term ended Term ended Apr 29, 2016 · From the USPTO record | Term ended | Term ended Apr 29, 2016 | From the USPTO record |
| US 7,960,410 | Method for treating insulin resistance, abdominal obesity, hypertension, hyperinsulinemia, and elevated blood lipids with a cortisol inhibitor Lapsed on the fee record Ended Jun 14, 2015 · From the USPTO record | Lapsed on the fee record | Ended Jun 14, 2015 | From the USPTO record |
| US 7,217,505 | Method for determining whether condition is symptom of metabolic syndrome Lapsed on the fee record Ended May 15, 2015 · From the USPTO record | Lapsed on the fee record | Ended May 15, 2015 | From the USPTO record |
| US 6,642,236 | Methods for prophylactic treatment of cardiovascular disease with inhibitor of cortisol synthesis Term ended Ended no later than Aug 9, 2014 · From the USPTO record | Term ended | Ended no later than Aug 9, 2014 | From the USPTO record |
| US 6,410,339 | Preparation for diagnosis of the metabolic syndrome and diseases including the syndrome Lapsed on the fee record Ended Jun 25, 2014 · From the USPTO record | Lapsed on the fee record | Ended Jun 25, 2014 | From the USPTO record |
| US 6,274,582 | Preparation for the treatment of metabolic syndrome containing human growth hormone in combination with a cortisol synthesis inhibitor Lapsed on the fee record Ended Aug 14, 2013 · From the USPTO record | Lapsed on the fee record | Ended Aug 14, 2013 | From the USPTO record |
| US 6,881,739 | Use of cortisol antagonists in the treatment of heart failure Lapsed on the fee record Ended Apr 19, 2013 · From the USPTO record | Lapsed on the fee record | Ended Apr 19, 2013 | From the USPTO record |
| US 5,849,740 | Methods for using ketoconazole and related substances in medicaments for treatment of type II diabetes Term ended Term ended no later than Dec 15, 2018 · Low confidence | Term ended | Term ended no later than Dec 15, 2018 | Low confidence |